Cargando…

A Simple Method for Assessment of Human Anti-Neu5Gc Antibodies Applied to Kawasaki Disease

N-Glycolylneuraminic acid (Neu5Gc) is an immunogenic sugar of dietary origin that metabolically incorporates into diverse native glycoconjugates in humans. Anti-Neu5Gc antibodies are detected in all human sera, though with variable levels and epitope-recognition profiles. These antibodies likely pla...

Descripción completa

Detalles Bibliográficos
Autores principales:	Padler-Karavani, Vered, Tremoulet, Adriana H., Yu, Hai, Chen, Xi, Burns, Jane C., Varki, Ajit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3592828/ https://www.ncbi.nlm.nih.gov/pubmed/23520510 http://dx.doi.org/10.1371/journal.pone.0058443

Ejemplares similares

Editorial: Human Antibodies Against the Dietary Non-human Neu5Gc-Carrying Glycans in Normal and Pathologic States
por: Soulillou, Jean-Paul, et al.
Publicado: (2020)

Anti-Neu5Gc and anti-non-Neu5Gc antibodies in healthy humans
por: Gao, Bingsi, et al.
Publicado: (2017)

Absence of Neu5Gc and Presence of Anti-Neu5Gc Antibodies in Humans—An Evolutionary Perspective
por: Altman, Meghan O., et al.
Publicado: (2019)

Association between Neu5Gc carbohydrate and serum antibodies against it provides the molecular link to cancer: French NutriNet-Santé study
por: Bashir, Salam, et al.
Publicado: (2020)

Human evolutionary loss of epithelial Neu5Gc expression and species-specific susceptibility to cholera
por: Alisson-Silva, Frederico, et al.
Publicado: (2018)

At least two Fc Neu5Gc residues of monoclonal antibodies are required for binding to anti-Neu5Gc antibody
por: Yu, Chuanfei, et al.
Publicado: (2016)

From “Serum Sickness” to “Xenosialitis”: Past, Present, and Future Significance of the Non-human Sialic Acid Neu5Gc
por: Dhar, Chirag, et al.
Publicado: (2019)

Sensitive and Specific Detection of the Non-Human Sialic Acid N-Glycolylneuraminic Acid In Human Tissues and Biotherapeutic Products
por: Diaz, Sandra L., et al.
Publicado: (2009)

Erratum: At least two Fc Neu5Gc residues of monoclonal antibodies are required for binding to anti-Neu5Gc antibody
por: Yu, Chuanfei, et al.
Publicado: (2017)

Prevalence of Anti-Neu5Gc Antibodies in Patients with Hypothyroidism
por: Eleftheriou, Phaedra, et al.
Publicado: (2014)

Evolution of sialic acids: Implications in xenotransplant biology
por: Paul, Anu, et al.
Publicado: (2018)

Glycosylated Biotherapeutics: Immunological Effects of N-Glycolylneuraminic Acid
por: Yehuda, Sharon, et al.
Publicado: (2020)

Novel mechanism for the generation of human xeno-autoantibodies against the nonhuman sialic acid N-glycolylneuraminic acid
por: Taylor, Rachel E., et al.
Publicado: (2010)

Xenotransplantation: The Way beyond and Ahead toward Clinical Application
por: Iop, Laura, et al.
Publicado: (2018)

Polyclonal human antibodies against glycans bearing red meat-derived non-human sialic acid N-glycolylneuraminic acid are stable, reproducible, complex and vary between individuals: Total antibody levels are associated with colorectal cancer risk
por: Samraj, Annie N., et al.
Publicado: (2018)

Treatment Response in Kawasaki Disease Is Associated with Sialylation Levels of Endogenous but Not Therapeutic Intravenous Immunoglobulin G
por: Ogata, Shohei, et al.
Publicado: (2013)

Challenging the Role of Diet-Induced Anti-Neu5Gc Antibodies in Human Pathologies
por: Soulillou, Jean-Paul, et al.
Publicado: (2020)

Synthesis of N-Glycolylneuraminic Acid (Neu5Gc) and Its Glycosides
por: Kooner, Anoopjit Singh, et al.
Publicado: (2019)

Anti-ganglioside antibodies induced in chickens by an alum-adsorbed anti-idiotype antibody targeting NeuGcGM3
por: Guthmann, Marcelo D., et al.
Publicado: (2013)

The Possible Role of Anti-Neu5Gc as an Obstacle in Xenotransplantation
por: Tector, Alfred Joseph, et al.
Publicado: (2020)

Editorial: Kawasaki Disease
por: Ayusawa, Mamoru, et al.
Publicado: (2021)

Novel data-mining approach identifies biomarkers for diagnosis of Kawasaki disease
por: Tremoulet, Adriana H., et al.
Publicado: (2015)

A Comparative Study of N-glycolylneuraminic Acid (Neu5Gc) and Cytotoxic T Cell (CT) Carbohydrate Expression in Normal and Dystrophin-Deficient Dog and Human Skeletal Muscle
por: Martin, Paul T., et al.
Publicado: (2014)

P3 mAb: An Immunogenic Anti-NeuGcGM3 Antibody with Unusual Immunoregulatory Properties
por: Martínez, Darel, et al.
Publicado: (2012)

N-Glycolylneuraminic Acid (Neu5Gc) Null Large Animals by Targeting the CMP-Neu5Gc Hydroxylase (CMAH)
por: Perota, Andrea, et al.
Publicado: (2019)

Long-term health outcomes in young adults after Kawasaki disease
por: Daniels, Lori B., et al.
Publicado: (2022)

Biomarkers of Inflammation and Fibrosis in Kawasaki Disease Patients Years After Initial Presentation With Low Ejection Fraction
por: Hoshino, Shinsuke, et al.
Publicado: (2019)

Directed Evolution of Therapeutic Antibodies Targeting Glycosylation in Cancer
por: Amon, Ron, et al.
Publicado: (2020)

DOACs in Patients With Giant Coronary Artery Aneurysms After Kawasaki Disease
por: Dummer, Kirsten B., et al.
Publicado: (2023)

Nontypeable Haemophilus influenzae Has Evolved Preferential Use of N-Acetylneuraminic Acid as a Host Adaptation
por: Ng, Preston S. K., et al.
Publicado: (2019)

Unbiased Screening of Kawasaki Disease Sera for Viral Antigen Exposure
por: Quiat, Daniel, et al.
Publicado: (2017)

Seasonality of Kawasaki Disease: A Global Perspective
por: Burns, Jane C., et al.
Publicado: (2013)

Wild and domestic animals variably display Neu5Ac and Neu5Gc sialic acids
por: Nemanichvili, Nikoloz, et al.
Publicado: (2022)

Exposure of Children to Rural Lifestyle Factors Associated With Protection Against Allergies Induces an Anti-Neu5Gc Antibody Response
por: Frei, Remo, et al.
Publicado: (2019)

Inﬂiximab for intensification of primary therapy for patients with Kawasaki disease and coronary artery aneurysms at diagnosis
por: Miyata, Koichi, et al.
Publicado: (2023)

Endothelial Cell Response in Kawasaki Disease and Multisystem Inflammatory Syndrome in Children
por: Kim, Jihoon, et al.
Publicado: (2023)

118 Transcriptional Profiling Discriminates Complete and Incomplete Kawasaki Disease (KD) from Adenovirus infection (HAdV)
por: Jaggi, Preeti, et al.
Publicado: (2014)

RNA Sequencing Reveals Beneficial Effects of Atorvastatin on Endothelial Cells in Acute Kawasaki Disease
por: Shimizu, Chisato, et al.
Publicado: (2022)

A deep convolutional neural network for Kawasaki disease diagnosis
por: Xu, Ellen, et al.
Publicado: (2022)

Xenogeneic Neu5Gc and self-glycan Neu5Ac epitopes are potential immune targets in MS
por: Boligan, Kayluz F., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_v7rtfebhsjq996heri7jmdvl2p